Cargando…
Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression
Estrogen receptor (ER)-positive breast cancer patients may turn ER-negative and develop acquired drug resistance, which compromises the efficacy of endocrine therapy. By investigating the phenomenon that gefitinib can re-sensitise tamoxifen (TAM)-resistant MCF-7 breast cancer cells (MCF-7/TAM) to TA...
Autores principales: | Zhang, Xia, Zhang, Bin, Liu, Jie, Liu, Jiwei, Li, Changzheng, Dong, Wei, Fang, Shu, Li, Minmin, Song, Bao, Tang, Bo, Wang, Zhehai, Zhang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314651/ https://www.ncbi.nlm.nih.gov/pubmed/25644501 http://dx.doi.org/10.1038/srep07835 |
Ejemplares similares
-
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
por: Hutcheson, Iain R, et al.
Publicado: (2007) -
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
por: Hutcheson, Iain R., et al.
Publicado: (2018) -
Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse.
por: Iino, Y., et al.
Publicado: (1991) -
The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells
por: Wang, Lijun, et al.
Publicado: (2021) -
The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer
por: Liu, Shu-Shu, et al.
Publicado: (2020)